Page last updated: 2024-11-01

nifedipine and Chlamydia pneumoniae Infections

nifedipine has been researched along with Chlamydia pneumoniae Infections in 1 studies

Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.

Research Excerpts

ExcerptRelevanceReference
"Nifedipine treatment increased expression of ferroportin 1 in the spleen, whereas splenic levels of the iron storage protein ferritin and serum iron concentrations were reduced."1.37Nifedipine affects the course of Salmonella enterica serovar Typhimurium infection by modulating macrophage iron homeostasis. ( Bellmann-Weiler, R; Fang, FC; Mair, SM; Moser, PL; Muehlbacher, T; Nairz, M; Schroll, A; Talasz, H; Theurl, I; Weiss, G, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mair, SM1
Nairz, M1
Bellmann-Weiler, R1
Muehlbacher, T1
Schroll, A1
Theurl, I1
Moser, PL1
Talasz, H1
Fang, FC1
Weiss, G1

Other Studies

1 other study available for nifedipine and Chlamydia pneumoniae Infections

ArticleYear
Nifedipine affects the course of Salmonella enterica serovar Typhimurium infection by modulating macrophage iron homeostasis.
    The Journal of infectious diseases, 2011, Sep-01, Volume: 204, Issue:5

    Topics: Animals; Bacterial Load; Calcium Channel Blockers; Cation Transport Proteins; Cell Line; Chlamydophi

2011